Résultats de recherche
14 oct. 2024 · J. P. Friedmann-Angeli and A. F. dos Santos highlight two complementary studies recently published in EMBO Mol. Med. reporting examples of alterations in lipid metabolism that can promote targetable vulnerabilities for breast tumors with poor prognosis.
- Connexion
J. P. Friedmann-Angeli and A. F. dos Santos highlight two...
- Article Collections
Download the PDF . Angiogenesis & Vascular Biology (2017) We...
- For Reviewers
About EMBO Molecular Medicine. EMBO Molecular Medicine is...
- Customer Service
EMBO Molecular Medicine. Volume 16, Issue 10, Oct 2024. This...
- For Authors
EMBO Molecular Medicine is an open access journal in the...
- Editors & Board
Zeljko joined EMBO Molecular Medicine as a Scientific Editor...
- Connexion
1 janv. 2024 · N. Meza and G. Guenechea discuss novel genetic variants identified in telomere biology disorder dyskeratosis congenita (DC) and DC-like patients, as reported by Tummala and colleagues in this issue of EMBO Mol Med. Abstract. Full text. PDF.
EMBO Molecular Medicine is an open access online journal published by Wiley-Blackwell on behalf of EMBO. The quality of the journal is guaranteed by the editorial and advisory boards, consisting of leading researchers in the field of molecular medicine, together with the commitment to scientific excellence and the professionalism of EMBO Editors.
5 août 2009 · Research articles report novel molecular research highly relevant to the understanding, prevention, treatment or cure of human diseases. Reports are concise manuscripts that highlight a specific finding, model or methodology with a high impact on the field of molecular medicine.
27 nov. 2017 · From funds allocation to highly specialised research, diagnosis and innovative therapeutic strategies, Klein and Gahl comment on rare diseases and how they actively contribute to the advancement of molecular medicine.
EMBO Molecular Medicine est une revue médicale en libre accès, évaluée par les pairs couvrant la recherche en médecine moléculaire. La revue a été publiée par Wiley-Blackwell en collaboration avec l'Organisation européenne de biologie moléculaire depuis son lancement en 2009, jusqu'en décembre 2013, lorsque l'EMBO Press a ...
1 juin 2016 · DOI: 10.15252/emmm.201606210. Abstract. Despite continuing debate about the amyloid β-protein (or Aβ hypothesis, new lines of evidence from laboratories and clinics worldwide support the concept that an imbalance between production and clearance of Aβ42 and related Aβ peptides is a very early, often initiating factor in Alzheimer's disease (AD).
